Blueprint Medicines Corp Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Blueprint Medicines Corp quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Blueprint Medicines Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $4.55M, a 3.2% increase year-over-year.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2023 was $17.7M, a 11.6% increase from 2022.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2022 was $15.9M, a 6.68% increase from 2021.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2021 was $14.9M, a 3.13% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.7M +$1.85M +11.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $15.9M +$995K +6.68% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $14.9M +$452K +3.13% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $14.4M +$2.2M +17.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $12.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.